FIELD: biotechnology.
SUBSTANCE: invention relates to a biomedical cell product (BMCP), as well as to a method of its production. The method involves isolating a leukoconcentrate of autologous or allogeneic mobilized mononuclear cells by peripheral blood leukocytopheresis or exfusion of native bone marrow, purifying the isolated leukoconcentrate from erythrocytes and granulocytes, cultivating the hematopoietic stem cells (HSC) and hematopoietic progenitor cells (HPC) contained in the purified leukoconcentrate, as well as incubation of the cell mass of HSCs and GPCs with a double-stranded human DNA drug to activate the hematopoietic, regulatory and regenerative properties of these cells.
EFFECT: invention is effective for the treatment of oncological, neurodegenerative, autoimmune diseases and injuries of the brain and spinal cord.
6 cl, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOMEDICAL CELL PRODUCT FOR TREATING NERVOUS DISEASES AND MENTAL DISORDERS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720002C1 |
| PERSONALIZED METHOD OF BONE MARROW RESTITUTION FOR CONTROLLING PROGRESSION AND RECURRENCES OF VARIOUS CIVILIZATION DISEASES, PREVENTING AGING AND SUDDEN DEATH | 2023 |
|
RU2817892C1 |
| BIOMEDICAL CELL PREPARATION | 2017 |
|
RU2647429C1 |
| BIOMEDICAL CELL PRODUCT, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2741769C2 |
| ANTITUMOR TARGET CELL PRODUCT, METHOD FOR ITS PRODUCTION AND ITS APPLICATION | 2018 |
|
RU2757812C2 |
| METHOD FOR OBTAINING BIOMEDICAL CELL PRODUCT FOR TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE AND AUTOIMMUNE DISEASES | 2019 |
|
RU2774350C2 |
| AUTOLOGIC HEMOPOIETIC STEM CELLS PREPARATION AND METHOD FOR PRODUCING, CRYOGENIC PRESERVING AND APPLYING IT IN TREATING TRAUMATIC NERVOUS SYSTEM DISEASE CASES | 2005 |
|
RU2283119C1 |
| METHOD FOR REMOTE ELECTROMAGNETIC MULTIWAVE RADIO NEUROENGINEERING OF HUMAN BRAIN | 2015 |
|
RU2621547C2 |
| STEM CELL PREPARATION WITH REPROGRAMMED CELL SIGNALLING, METHOD FOR MAKING THIS PREPARATION AND APPLICATION THEREOF | 2008 |
|
RU2428475C2 |
| COMBINATION CELL IMMUNOTHERAPY OF MALIGNANT TUMORS | 2020 |
|
RU2787623C2 |
